Skip to main navigation Skip to search Skip to main content

Development of innovative pharmacogenomic biomarkers for the personalization of therapy with thiopurines in early-onset inflammatory bowel disease patients

  • University of Trieste

Project: Research

Project Details

Description

Azathioprine (AZA) is an immunosuppressant used to treat inflammatory bowel diseases (IBD). It can induce adverse effects, particularly relevant for the very early onset (
StatusActive
Effective start/end date4/02/25 → 3/02/27

Funding

  • MUR - Ministero dell'Università e Ricerca

UN Sustainable Development Goals

In 2015, UN member states agreed to 17 global Sustainable Development Goals (SDGs) to end poverty, protect the planet and ensure prosperity for all. This project contributes towards the following SDG(s):

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

Access Project

Fingerprint

Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.
View full fingerprint